JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M602446200 on April 19, 2006 Originally published In Press as doi:10.1074/jbc.M602446200 on April 6, 2006

J. Biol. Chem., Vol. 281, Issue 25, 16985-16990, June 23, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/25/16985    most recent
M602446200v2
M602446200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vines, A.
Right arrow Articles by Pillarisetti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vines, A.
Right arrow Articles by Pillarisetti, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Anti-inflammatory Role for Glycogen Synthase Kinase-3beta in the Inhibition of Tumor Necrosis Factor-{alpha}- and Interleukin-1beta-induced Inflammatory Gene Expression*Formula

Angela Vines{ddagger}1, Sientay Cahoon{ddagger}, Ira Goldberg§, Uday Saxena{ddagger}, and Sivaram Pillarisetti{ddagger}

From the {ddagger}Reddy US Therapeutics, Dr. Reddy's Laboratories, Norcross, Georgia 30071 and §Department of Medicine, Columbia University, New York, New York 10032

Glycogen synthase kinase-3beta (GSK-3beta) is a serine/threonine kinase with a broad array of cellular targets, such as cytoskeletal proteins and transcription factors. Recent studies with GSK-3beta-null mice showed impaired NF{kappa}B-mediated survival responses. Because NF{kappa}B serves a dual role as a key regulator of cytokine-induced inflammatory gene expression and apoptosis, we investigated whether modulation of GSK-3beta expression affects cytokine-induced and NF{kappa}B-mediated inflammatory gene expression. We observed that tumor necrosis factor-{alpha} (TNF-{alpha}) and interleukin-1beta (IL-1beta) treatment of primary cultures of human microvascular cells reduced net endogenous active GSK-3beta protein levels while inducing inflammatory cytokine (IL-6 and monocyte chemoattractant protein-1 (MCP-1)) expression. Interestingly, inhibition of GSK-3beta by antisense oligonucleotides or pharmacological agent (10 mM lithium) potentiated TNF-induced expression of IL-6 and MCP-1 by 2–6-fold suggesting that inhibition of GSK-3beta under inflammatory conditions (exposure to TNF-{alpha} and IL-1beta) may contribute to enhanced cytokine expression. Overexpression of GSK-3beta in endothelial cells, in contrast, significantly inhibited (by 70%, p < 0.01) both TNF-{alpha} and IL-1beta-induced expression of IL-6, MCP-1, and vascular cell adhesion molecule-1. Using adenoviruses in lipopolysaccharide-stimulated mice, overexpression of GSK-3beta significantly decreased TNF-{alpha} expression in lung and heart tissues (38 and 15%, respectively), further confirming the anti-inflammatory role of GSK-3beta. Overexpression of GSK-3beta did not affect the TNF-{alpha}-induced nuclear translocation of NF{kappa}B but reduced the nuclear half-life of TNF-{alpha}-induced NF{kappa}B considerably (by as much as 9 h) and enhanced phosphorylation (by as much as 33%). Interestingly, neither endothelial cell survival nor NF{kappa}B-mediated expression of anti-apoptotic genes was affected by GSK-3beta overexpression. We conclude that GSK-3beta selectively regulates NF{kappa}B-mediated inflammatory gene expression by controlling the flow of NF{kappa}B activity between transcription of inflammatory and survival genes.


Received for publication, March 15, 2006

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1.

1 To whom correspondence should be addressed: Reddy US Therapeutics, Dr. Reddy's Laboratories, 3065 Northwoods Circle, Norcross, GA 30071. Tel.: 770-446-9500; Fax: 770-446-1950; E-mail: avines{at}reddyus.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
T. J. Wiles, B. K. Dhakal, D. S. Eto, and M. A. Mulvey
Inactivation of Host Akt/Protein Kinase B Signaling by Bacterial Pore-forming Toxins
Mol. Biol. Cell, April 1, 2008; 19(4): 1427 - 1438.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-J. Wang, S.-Z. Lin, J.-S. Kuo, H.-Y. Huang, S.-F. Tzeng, C.-H. Liao, D.-C. Chen, and W.-F. Chen
Urocortin Modulates Inflammatory Response and Neurotoxicity Induced by Microglial Activation
J. Immunol., November 1, 2007; 179(9): 6204 - 6214.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.